Cargando…
Guidelines and tumor boards are required for solid organ recipients with de novo carcinoma
Autores principales: | Rousseau, Benoit, Guillemin, Aude, Tournigand, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497459/ https://www.ncbi.nlm.nih.gov/pubmed/31073369 http://dx.doi.org/10.18632/oncotarget.26860 |
Ejemplares similares
-
Board of Health, Organization and Committees
Publicado: (1875) -
Third Time’s a Charm — Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients
por: Williams, Winfred W., et al.
Publicado: (2021) -
Infections in Solid-Organ Transplant Recipients
por: Singh, Nina, et al.
Publicado: (2015) -
Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients
por: Breithaupt, Andrew D., et al.
Publicado: (2015) -
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)